TB meningitis is a major cause of death in Southern Africa, but the current diagnostic tests are not as quick or as sensitive as they need to be. Finding a sensitive, rapid test for TB meningitis has been elusive until now, but that is changing thanks to BioFISA II funding and researchers at Antrum Biotech.
The SANBio–BioFISA II Programme is fortunate to have female project leaders supervising some of the grants in their funding portfolio. In this profile we focus on Khilona Radia, the co-founder of Antrum Biotech, a University of Cape Town spin-off specialising in Healthcare Innovation.
A project receiving funding from the NEPAD Southern Africa Network for Biosciences / BioFISA II Programme, entitled Gene Dose EFV was awarded the 1st place award in GAP Biosciences/Medical Innovations at the recent Gauteng Acceleration Programme (GAP) event which was held in South Africa Gauteng on 17 November 2016.